RFP QuestBeta
OpenStage · planning

SUPPLY CHAIN COORDINATION LIMITED

Insulin pumps, continuous glucose monitoring products contributing to the delivery of hybrid closed loop pathways and associated products

Medical Equipment & PharmaCPV 33194000
Value£3000.0m
Deadline
Published6 Feb 2026
RegionNationwide
Who to contact
ivtherapycontracts@supplychain.nhs.uk

The procurement contact named on the official notice.

Contract value in context
£3000.0mtotal contract value
median £123k
this tender£0£3240.0m

This is a large award for Medical Equipment & Pharmaceuticals — above three-quarters of comparable contracts. Based on 9,456 valued Medical Equipment & Pharmaceuticals tenders in our corpus.

Match for your company
Sign up free to see how well this tender matches your company — the score, the signals that align, and where the gaps are.
The brief

NHS Supply Chain supports national diabetes services by enabling equitable access to advanced diabetes technologies, encouraging openness to innovation, and ensuring an appropriate balance between clinical outcomes, cybersecurity, interoperability, and value for money.

This notice is published to inform the market and to invite suppliers to participate in preliminary market engagement in accordance with the Procurement Act 2023.

NHS Supply Chain is exploring the potential establishment of an open framework agreement with a proposed duration of up to eight (8) years for the supply of insulin pumps, continuous glucose monitoring (CGM) devices, hybrid closed loop system components, and associated products and services.

The proposed scope may include, but is not limited to, tethered insulin pumps, patch insulin pumps, continuous glucose monitoring devices, products contributing to the functionality of hybrid closed loop insulin delivery systems, consumables, and smart insulin pens.

Precise quantities are unknown.

It is anticipated that indicative expenditure in the first year may be in the region of £240,000,000 to £250,000,000 GBP (excluding VAT).

This estimate is indicative only and may vary depending on the requirements of contracting authorities accessing the framework.

The estimated total value over the potential eight year duration is approximately £3,000,000,000 GBP (excluding VAT).

Any future framework agreement would support delivery of the NHS England Implementation Plan following the National Institute for Health and Care Excellence (NICE) Technology Appraisal TA943 – Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes, published on 19 December 2023.

Participation in this preliminary market engagement is voluntary and does not constitute a commitment by NHS Supply Chain to commence a procurement, to award a contract, or to include any participant in any future procurement process.

Any future procurement will be conducted in accordance with the Procurement Act 2023 and published via the Find a Tender Service as appropriate.

Any resulting framework agreement would be entered into between NHS Supply Chain and the appointed supplier(s)

Key requirements

What the supplier must deliver

01

NHS Supply Chain supports national diabetes services

NHS Supply Chain supports national diabetes services by enabling equitable access to advanced diabetes technologies, encouraging openness to innovation, and ensuring an appropriate balance between clinical outcomes, cybersecurity, interoperability, and value for money.

02

NHS Supply Chain is exploring the potential

NHS Supply Chain is exploring the potential establishment of an open framework agreement with a proposed duration of up to eight (8) years for the supply of insulin pumps, continuous glucose monitoring (CGM) devices, hybrid closed loop system components, and associated products and services.

03

Any future framework agreement would support delivery

Any future framework agreement would support delivery of the NHS England Implementation Plan following the National Institute for Health and Care Excellence (NICE) Technology Appraisal TA943.

04

Participation in this preliminary market engagement is

Participation in this preliminary market engagement is voluntary and does not constitute a commitment by NHS Supply Chain to commence a procurement, to award a contract, or to include any participant in any future procurement process.

05

Any resulting framework agreement would be entered

Any resulting framework agreement would be entered into between NHS Supply Chain and the appointed supplier(s).

Derived from the notice text — always confirm against the original documents.

Buyer intelligence

Make the case to bid

Reveal who to approach at SUPPLY CHAIN COORDINATION LIMITED, and generate a go-to-market strategy from their news, accounts and people.

Source & provenance
OCID
ocds-h6vhtk-0649a1
Stage
planning · Planning
Source
Find a Tender
Buyer ref
010763-2026
View the original notice on Find a Tender

Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.

Market context

Who wins this kind of work

The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.

Top suppliers & buyers in Medical Equipment & Pharmaceuticals

Assembling the market network…

SUPPLY CHAIN COORDINATION LIMITED’s tender network

Assembling the network…

Also open now

Similar open tenders

Insulin Infusion Pumps, Continuous Glucose Monitoring Systems and Associated Consumables

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Closes 10 Aug 2026Medical Equipment & Pharma
£140.0mValue

Hand Hygiene Associated Products and Services

SUPPLY CHAIN COORDINATION LIMITED

Closes 28 Jul 2026Education
£150.1mValue